HomeNewsIndiaIndia crosses 100-crore-vaccination mark | The Everest is yet to be conquered

India crosses 100-crore-vaccination mark | The Everest is yet to be conquered

India crossed the 100-crore (one-billion) mark in administering COVID-19 vaccination doses on October 21. The challenge to fully inoculate the country’s large population lies ahead.

October 21, 2021 / 13:45 IST
Story continues below Advertisement
Despite the hostile terrain, the northern state of Himachal Pradesh, where Malana is located, earlier this month became the first in India to administer at least one COVID-19 vaccine dose in all its adults. (Image: Reuters)
Despite the hostile terrain, the northern state of Himachal Pradesh, where Malana is located, earlier this month became the first in India to administer at least one COVID-19 vaccine dose in all its adults. (Image: Reuters)

India, on October 21, achieved the significant milestone of vaccinating 100 crore people against COVID-19. While this is a credible and commendable achievement given the size of its population, the country is yet to fully inoculate a significant proportion of its people.

It took India 278 days to administer 100 crore jabs, with more than 50 percent of the population getting the first dose and over 21 percent having received both doses.

Story continues below Advertisement

“Achieving the 1 billion vaccination mark in India is a remarkable feat,” said Chandrakant Lahariya, a Delhi based epidemiologist and public health expert. “This shows that if there is a will, the Indian healthcare system can deliver when required. While we should celebrate the milestone and the efforts of healthcare workers, we should also be mindful of the huge challenge ahead of vaccinating the remaining adult population.”

Overall, the progress of the vaccination drive has been good considering the size of our nation and the population, said Gautam Menon, professor at Ashoka University and an infectious disease and public policy expert. “The pace of vaccination has dipped in recent days to about 5-6 million from 9-10 million over the past few weeks, but the reason for this isn't clear. While 30 percent of the adult population has been fully vaccinated, a further 44 percent have only received one dose,” he added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show

Data show that the pace of vaccination has not been consistent, pointing to the herculean task ahead for the administration to fully inoculate the population.